These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18396401)

  • 21. [Synthesis and biological activity of hydrophosphoryl derivatives of amphotericin B].
    Belakhov VV; Shenin IuD; Arabiĭskiĭ RA; Shtil'bans EB
    Antibiot Khimioter; 1996; 41(7-8):4-8. PubMed ID: 8999761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of amphotericin B and its selected derivatives with membranes: molecular modeling studies.
    Baginski M; Czub J; Sternal K
    Chem Rec; 2006; 6(6):320-32. PubMed ID: 17304519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics.
    Jung SH; Lim DH; Jung SH; Lee JE; Jeong KS; Seong H; Shin BC
    Eur J Pharm Sci; 2009 Jun; 37(3-4):313-20. PubMed ID: 19491021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amphotericin B: from derivatives to covalent targeted conjugates.
    Sedlák M
    Mini Rev Med Chem; 2009 Oct; 9(11):1306-16. PubMed ID: 19929807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of biodegradation of poly(ethylene glycol)s and poly(propylene glycol)s.
    Zgoła-Grześkowiak A; Grześkowiak T; Zembrzuska J; Łukaszewski Z
    Chemosphere; 2006 Jul; 64(5):803-9. PubMed ID: 16343594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-methyl-N-D-fructopyranosylamphotericin B methyl ester, new amphotericin B derivative of low toxicity.
    Grzybowska J; Sowiński P; Gumieniak J; Zieniawa T; Borowski E
    J Antibiot (Tokyo); 1997 Aug; 50(8):709-11. PubMed ID: 9315089
    [No Abstract]   [Full Text] [Related]  

  • 27. Preparation and therapeutic efficacy of polysorbate-80-coated amphotericin B/PLA-b-PEG nanoparticles.
    Ren T; Xu N; Cao C; Yuan W; Yu X; Chen J; Ren J
    J Biomater Sci Polym Ed; 2009; 20(10):1369-80. PubMed ID: 19622277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cholesterol on the release of amphotericin B from PEG-phospholipid micelles.
    Vakil R; Kwon GS
    Mol Pharm; 2008; 5(1):98-104. PubMed ID: 18159926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y; Akşit F; Kiraz N; Kiremitçi A
    Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and structure-activity relationships of amides of amphotericin B.
    Jarzebski A; Falkowski L; Borowski E
    J Antibiot (Tokyo); 1982 Feb; 35(2):220-9. PubMed ID: 7076567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of poly(ethylene glycol)-b-poly(epsilon-caprolactone) by two-dimensional liquid chromatography.
    Ahmed H; Trathnigg B
    J Sep Sci; 2009 May; 32(9):1390-400. PubMed ID: 19350584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring carbohydrate enzymatic reactions by quantitative in vitro microdialysis.
    Modi SJ; LaCourse WR
    J Chromatogr A; 2006 Jun; 1118(1):125-33. PubMed ID: 16546198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design of the complex between manganese porphyrins and catalase-poly(ethylene glycol) conjugates for a new antioxidant.
    Asayama S; Hanawa T; Nagaoka S; Kawakami H
    Mol Pharm; 2007; 4(3):484-6. PubMed ID: 17385889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioactive fluorinated derivative of amphotericin B.
    Matsumori N; Umegawa Y; Oishi T; Murata M
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3565-7. PubMed ID: 15963721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amphotericin B. Synthesis of its aglycone (amphoteronolide B) and degradation.
    Masamune S
    Ann N Y Acad Sci; 1988; 544():168-79. PubMed ID: 3214066
    [No Abstract]   [Full Text] [Related]  

  • 36. Susceptibility of clinical isolates of Cryptococcus neoformans to amphotericin B using time-kill methodology.
    Pappalardo MC; Szeszs MW; Martins MA; Baceti LB; Bonfietti LX; Purisco SU; Baez AA; Melhem MS
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):146-51. PubMed ID: 19345042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells.
    Sahu A; Bora U; Kasoju N; Goswami P
    Acta Biomater; 2008 Nov; 4(6):1752-61. PubMed ID: 18524701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans.
    An M; Shen H; Cao Y; Zhang J; Cai Y; Wang R; Jiang Y
    Int J Antimicrob Agents; 2009 Mar; 33(3):258-63. PubMed ID: 19095412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of alternative dosing regimens of poly-aggregated amphotericin B.
    Espada R; Valdespina S; Molero G; Dea MA; Ballesteros MP; Torrado JJ
    Int J Antimicrob Agents; 2008 Jul; 32(1):55-61. PubMed ID: 18534826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel strategy for bioconjugation: synthesis and preliminary evaluation with amphotericin B.
    Zumbuehl A; Stano P; Sohrmann M; Peter M; Walde P; Carreira EM
    Org Biomol Chem; 2007 May; 5(9):1339-42. PubMed ID: 17464400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.